However, the detailed mechanisms regarding the antidiabetic effect of BBR, especially whether it promotes insulin secretion, remain poorly understood, limiting the clinical use of BBR
Gen Z appeared to be leading the trend, with 89% of respondents aged 18 to 28 reporting they had microdosed in the past or were currently doing so
We again see that here
However, LSDM is considered to be a relatively low PDA risk group because PDA was reported to have no causal relationship with LSDM(Molina-Montes et al., 2021)
Take the supplement in the middle of a meal rather than at the beginning or end, sandwiching it between bites of food
Medical prescribers are clearly listed through OpenLoop and affiliated clinical entities, so no concerns on the provider side